GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Monday reported a loss of $31.3 million in its fourth quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of 58 cents. Earnings, adjusted for non-recurring costs, were 5 cents per share.
The biopharmaceutical company posted revenue of $194.7 million in the period.
For the year, the company reported a loss of $190.6 million, or $3.60 per share. Revenue was reported as $1.04 billion.
For the current quarter ending in March, Emergent Biosolutions said it expects revenue in the range of $200 million to $240 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
